Literature DB >> 28463419

Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions.

Christine Lin1,2, Salman R Khetani2.   

Abstract

Drug clearance rates from the body can determine drug exposure that can affect efficacy or toxicity. Thus, accurate prediction of drug clearance during preclinical development can help guide dose selection in humans, but animal testing is not always predictive of human outcomes. Because hepatic drug metabolism is a rate-limiting step in the overall clearance of many drugs, primary human hepatocytes (PHHs) in suspension cultures or monolayers are used for drug clearance predictions. Yet, the precipitous decline in drug metabolism capacity can lead to significant underestimation of clearance rates, particularly for low turnover compounds that have desirable one-pill-a-day dosing regimens. In contrast, micropatterned co-cultures (MPCCs) of PHHs and fibroblasts display phenotypic stability for several weeks and can help mitigate the limitations of conventional cultures. Here, we describe protocols to create and use MPCCs for drug clearance predictions, and for modeling clinically-relevant drug-drug interactions that can affect drug clearance. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  3T3-J2 fibroblasts; cytochrome P450; drug metabolism; low turnover drugs; primary human hepatocytes

Mesh:

Substances:

Year:  2017        PMID: 28463419      PMCID: PMC5495000          DOI: 10.1002/cptx.23

Source DB:  PubMed          Journal:  Curr Protoc Toxicol        ISSN: 1934-9254


  33 in total

1.  Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac.

Authors:  Tom S Chan; Hongbin Yu; Amanda Moore; Salman R Khetani; Salman R Kehtani; Donald Tweedie
Journal:  Drug Metab Dispos       Date:  2013-08-19       Impact factor: 3.922

Review 2.  Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation.

Authors:  E L LeCluyse
Journal:  Eur J Pharm Sci       Date:  2001-07       Impact factor: 4.384

Review 3.  Clinical pharmacokinetics.

Authors:  A J Atkinson; W Kushner
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

4.  Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats.

Authors:  Regis Baudoin; Audrey Legendre; Sebastien Jacques; Jerome Cotton; Frederic Bois; Eric Leclerc
Journal:  J Pharm Sci       Date:  2013-12-10       Impact factor: 3.534

5.  Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type.

Authors:  C Guguen-Guillouzo; B Clément; G Baffet; C Beaumont; E Morel-Chany; D Glaise; A Guillouzo
Journal:  Exp Cell Res       Date:  1983-01       Impact factor: 3.905

6.  Establishment of a hepatocyte-kupffer cell coculture model for assessment of proinflammatory cytokine effects on metabolizing enzymes and drug transporters.

Authors:  Theresa V Nguyen; Okechukwu Ukairo; Salman R Khetani; Michael McVay; Chitra Kanchagar; Wolfgang Seghezzi; Gulesi Ayanoglu; Onyi Irrechukwu; Raymond Evers
Journal:  Drug Metab Dispos       Date:  2015-03-04       Impact factor: 3.922

7.  Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver.

Authors:  Matthew D Davidson; Michael Lehrer; Salman R Khetani
Journal:  Tissue Eng Part C Methods       Date:  2015-01-30       Impact factor: 3.056

8.  Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Authors:  Alexander Ploss; Salman R Khetani; Christopher T Jones; Andrew J Syder; Kartik Trehan; Valeriya A Gaysinskaya; Kathy Mu; Kimberly Ritola; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

9.  Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.

Authors:  Amir Shlomai; Robert E Schwartz; Vyas Ramanan; Ankit Bhatta; Ype P de Jong; Sangeeta N Bhatia; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

10.  T-cadherin modulates hepatocyte functions in vitro.

Authors:  Salman R Khetani; Alice A Chen; Barbara Ranscht; Sangeeta N Bhatia
Journal:  FASEB J       Date:  2008-07-17       Impact factor: 5.191

View more
  6 in total

1.  Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures.

Authors:  Matthew D Davidson; Joshua Pickrell; Salman R Khetani
Journal:  Toxicology       Date:  2020-12-24       Impact factor: 4.221

Review 2.  Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.

Authors:  Alexandre J S Ribeiro; Xinning Yang; Vikram Patel; Rajnikanth Madabushi; David G Strauss
Journal:  Clin Pharmacol Ther       Date:  2019-06-04       Impact factor: 6.875

3.  Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers.

Authors:  Liliana Mancio-Silva; Heather E Fleming; Alex B Miller; Stuart Milstein; Abigail Liebow; Patrick Haslett; Laura Sepp-Lorenzino; Sangeeta N Bhatia
Journal:  Cell Metab       Date:  2019-03-05       Impact factor: 27.287

4.  LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.

Authors:  Guilin Qiao; Lyonell B Kone; Evan H Phillips; Steve Seung-Young Lee; Grace E Brown; Salman R Khetani; Archana Thakur; Lawrence G Lum; Bellur S Prabhakar; Ajay V Maker
Journal:  Oncogene       Date:  2022-02-17       Impact factor: 8.756

5.  Co-culture with mouse embryonic fibroblasts improves maintenance of metabolic function of human small hepatocyte progenitor cells.

Authors:  Srikumar Sengupta; Brian Johnson; Morten Seirup; Hamisha Ardalani; Bret Duffin; Gregory A Barrett-Wilt; Ron Stewart; James A Thomson
Journal:  Curr Res Toxicol       Date:  2020-08-26

Review 6.  In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations.

Authors:  Constance N Wose Kinge; Nimisha H Bhoola; Anna Kramvis
Journal:  Viruses       Date:  2020-03-23       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.